BNP Paribas Asset Management
NEO icon

BNP Paribas Asset Management’s NeoGenomics NEO Stock Holding History

BNP Paribas Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4K Sell
2,429
-311
-11% -$3K ﹤0.01% 1883
2026
Q1 		$20.3K Buy
2,740
+705
+35% +$7.42K ﹤0.01% 2026
2025
Q4 		$24K Buy
2,035
+540
+36% +$5.83K ﹤0.01% 1892
2025
Q3 		$12K Buy
1,495
+103
+7% +$721 ﹤0.01% 1572
2025
Q2 		$10K Buy
+1,392
New +$11.2K ﹤0.01% 1777

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

BNP Paribas Asset Management's NEO Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its NeoGenomics (NEO) stake by 11% in Q2 2026, selling an estimated $3K and leaving 2,429 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

BNP Paribas Asset Management first reported a position in NEO in Q2 2025 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • BNP Paribas Asset Management held 2,429 shares of NeoGenomics worth $35.4K as of Q2 2026.
  • BNP Paribas Asset Management sold 311 NeoGenomics shares in Q2 2026, an estimated $3K.
  • NeoGenomics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1883 holding.
  • BNP Paribas Asset Management first reported a position in NeoGenomics in Q2 2025 and has held it in 5 quarters since.
  • 202 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.